Genome modification using guide polynucleotide/cas endonuclease systems and methods of use
Abstract
Compositions and methods are provided for genome modification of a target sequence in the genome of a cell. The methods and compositions employ a guide polynucleotide/Cas endonuclease system to provide an effective system for modifying or altering target sites within the genome of a cell or organism. Once a genomic target site is identified, a variety of methods can be employed to further modify the target sites such that they contain a variety of polynucleotides of interest. Compositions and methods are also provided for editing a nucleotide sequence in the genome of a cell. Breeding methods and methods for selecting plants utilizing a two component RNA polynucleotide and Cas endonuclease system are also disclosed.
Claims
exact text as granted — not AI-modified1 .- 43 . (canceled)
44 . A method for modifying a target site in a eukaryotic cell, the method comprising:
providing the eukaryotic cell with a guide polynucleotide that complexes with a Cas endonuclease, the guide polynucleotide comprising:
a) a Variable Targeting (VT) domain that is complementary to a polynucleotide sequence of the target site, wherein the VT domain is at least 12 nucleotides in length and comprises deoxyribonucleic acid; and
b) a Cas Endonuclease Recognition (CER) domain that interacts with the Cas endonuclease,
introducing a double strand break in the polynucleotide sequence of the target site upon complexing of the guide polynucleotide and the Cas endonuclease.
45 . The method of claim 44 , further comprising:
identifying eukaryotic cells comprising a modified target site, the modified target site comprising:
i. a substitution of at least one nucleotide;
ii. a deletion of at least one nucleotide;
iii. an insertion of at least one nucleotide; or
iv. a combination of i-iii.
46 . The method of claim 44 , further comprising:
providing the eukaryotic cell with a donor DNA comprising a polynucleotide of interest; and identifying eukaryotic cells comprising the polynucleotide of interest integrated at the target site.
47 . The method of claim 44 , further comprising:
providing the eukaryotic cell with the Cas endonuclease.
48 . The method of claim 44 , wherein the VT domain and the CER domain are located on a single molecule.
49 . The method of claim 44 , wherein the guide polynucleotide provided to the eukaryotic cell is less than 1 μg.
50 . The method of claim 44 , wherein the guide polynucleotide provided to the eukaryotic cell is between, and inclusive of, 50 ng and 100 ng.
51 . The method of claim 44 , wherein the guide polynucleotide provided to the eukaryotic cell is at least 50 ng and less than 1 ug.
52 . The method of claim 44 , wherein the guide polynucleotide is provided to the eukaryotic cell by particle bombardment.
53 . The method of claim 44 , wherein the guide polynucleotide is provided to the eukaryotic cell by Agrobacterium -mediated transformation.
54 . The method of claim 44 , wherein the target site is chromosomal DNA.
55 . The method of claim 44 , wherein the eukaryotic cell is a plant cell.
56 . The method of claim 55 , wherein the eukaryotic cell is a monocot plant cell.
57 . The method of claim 55 , wherein providing the eukaryotic cell with the guide polynucleotide comprises delivering the guide polynucleotide to a plant embryo.
58 . The method of claim 57 , wherein the guide polynucleotide is provided to the plant embryo by particle bombardment.
59 . The method of claim 57 , wherein the guide polynucleotide is provided to the plant embryo by Agrobacterium -mediated transformation.Join the waitlist — get patent alerts
Track US2022177900A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.